Materials Today Bio

Materials Today Bio is a fully open-access multidisciplinary journal published by Elsevier whose first volume appeared in 2019, that is devoted to the interface between biology and materials science, chemistry, physics, engineering and medicine, and that recorded a Journal Impact Factor of 11.0 for 2025（Materials Today Bio）（今日材料生物）由（Elsevier）出版，是一份完全开放获取的多学科期刊，2019 年第 1 卷面世，专注生物学与材料科学、化学、物理学、工程学及医学之间的交叉界面，2025 年影响因子为 11.0。

Scope

• Its stated remit runs from the design and assembly of novel structures, through their functionalization and interaction with biological systems, to bioimaging, therapies and diagnostics in healthcare期刊自述的报道范围起于新型结构的设计与组装，经由其功能化及与生物系统的相互作用，终于医疗健康中的生物成像、治疗与诊断。
• Publisher index terms identify the core sub-fields as biomaterials, tissue engineering, nanomedicine, biosensors, bioinspired surfaces and biomimetics出版方的主题标引词把核心子领域标定为生物材料、组织工程、纳米医学、生物传感器、仿生表面与仿生学。
• As part of the Materials Today family of journals, the title offers authors rigorous peer review, rapid decisions and high visibility, in the publisher's own wording按出版方自己的表述，该刊作为（Materials Today）期刊家族的一员，为作者提供严格的同行评审、快速的编辑决断与高度的可见性。
• It sits within the Elsevier biomaterials science portfolio next to the long-running journal Biomaterials and the companion title Biomaterials Advances它被归入（Elsevier）的生物材料科学期刊群，与长期深耕的（Biomaterials）及姊妹刊（Biomaterials Advances）并列。
• Every article is immediately open access under a Creative Commons licence, with CC BY, CC BY-NC and CC BY-NC-ND among the options funded by an article publishing charge每篇论文即时开放获取，可在（CC BY）、（CC BY-NC）、（CC BY-NC-ND）等知识共享许可中择一发布，费用由文章处理费覆盖。
• In library classification the journal is shelved between medicine and biology in their general aspects, reflecting its translational outlook在图书分类体系中，该刊被归入医学（综合）与生物学（综合）之间，反映出其转化研究的取向。

History

• Elsevier launched the journal as an open-access venue for the biology and materials interface and its first volume, organized by standalone article numbers rather than pagination, appeared in 2019 with papers such as a microfluidic small-angle X-ray scattering study of mechanoresponsive liposomes（Elsevier）将本刊定位为服务生物学与材料界面研究的开放获取平台，第 1 卷于 2019 年面世，采用独立文章编号而非连续页码，早期论文之一即以微流控与小角 X 射线散射研究力响应脂质体。^[1]
• The family traces back to the flagship Materials Today, established in 1998 as a news and review source and later turned by Elsevier into a series of specialist companions such as Applied Materials Today, Materials Today Nano, Materials Today Physics and Materials Today Advances该家族可追溯到 1998 年创刊的旗舰刊（Materials Today）；它最初是材料界的新闻与综述来源，后被（Elsevier）拓展为一系列专业姊妹刊，包括（Applied Materials Today）、（Materials Today Nano）、（Materials Today Physics）、（Materials Today Advances）等。
• Its founding added the biology title to a wave of open-access family members such as Materials Today Advances, Materials Today Electronics and Materials Today Catalysis, and publication has stayed continuous and article-based ever since它的创办把生物主题刊纳入了与（Materials Today Advances）、（Materials Today Electronics）、（Materials Today Catalysis）等开放获取新刊并列的浪潮，此后出版形态始终保持基于文章的连续在线模式。
• The journal was admitted to the Science Citation Index Expanded and is also covered by Scopus, the Directory of Open Access Journals and PubMed Central该刊被（SCIE）核心合集收录，同时见于（Scopus）、开放获取期刊目录（DOAJ）与（PubMed Central）。
• Its authoritative impact history records a Journal Impact Factor of 7.348 for 2021 and 10.761 for 2022权威影响因子序列显示，其 2021 年为 7.348，2022 年为 10.761。
• For 2024 the recorded value is 10.2 and for 2025 a Journal Impact Factor of 11.0, placing it in the first quartile of the two Journal Citation Reports categories of engineering with biomedical applications and materials science with biomaterials2024 年记录值为 10.2，2025 年影响因子达 11.0，在（JCR）的工程：生物医学与材料科学：生物材料两个类目均列 Q1 区。

Editors

• The Editor-in-Chief named on the publisher's family page is Joao F. Mano, Full Professor in the Chemistry Department of the University of Aveiro in Portugal出版方家族页列出的主编为（Joao F. Mano），任葡萄牙阿威罗大学化学系讲席教授。
• He is also vice-director of the associated laboratory CICECO, the Aveiro Institute of Materials, and works on advanced biomaterials and cells for regenerative and personalized medicine他兼任联合实验室（CICECO）阿威罗材料研究所副主任，研究以先进生物材料与细胞推动再生医学与个性化医疗。
• His publisher profile records two European Research Council Advanced Grants, more than seven hundred papers and editorial seats on twelve international journals before he took the helm其出版方简介载明，他曾获两项（ERC）高级别资助、发表七百多篇论文，并在执掌本刊之前担任 12 种国际期刊的编委。
• The most recent masthead carried by the publisher also lists Kun Qian of the School of Biomedical Engineering at Shanghai Jiao Tong University among the editors出版方最新刊面还将上海交通大学（Kun Qian）列为编辑团队成员。
• The publisher's bibliographic record describes the review model as single anonymous peer review, and the family page pledges rigorous review with rapid decisions出版方登记的书目信息将评审模式记为单匿名同行评审，家族页亦承诺严格评审与快速决断。
• Manuscripts are submitted and handled through a dedicated Editorial Manager portal maintained by Elsevier稿件经（Elsevier）维护的（Editorial Manager）专属投稿门户提交并流转。